The University of Colorado (CU) has signed an exclusive, worldwide licensing and collaboration agreements with Orphan Technologies to develop an enzyme replacement therapy for Cystathionine Beta-Synthase (CBS) -deficient homocystinuria. ...
Tags: Orphan Technologies, homocystinuria, Cystathionine Beta Synthase